Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, burping more than usual is a recognised side effect of Wegovy. Semaglutide slows the rate at which the stomach empties, and that delay means trapped gas has more time to build — leading to frequent belching in some people, particularly in the first few weeks of treatment or after a dose increase. It is a prescription-only medicine, so whether it is right for you is a decision made with a prescriber who reviews your full picture. Most people find burping settles as their body adjusts, though for some it remains a consistent companion throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing gastric emptying, the pace at which food moves from your stomach into your small intestine. That slowing is intentional: it extends fullness and blunts the post-meal spike in appetite. The side effect is that gas produced during digestion lingers longer in the upper GI tract, and your body's most efficient exit route is upward. The result is more frequent, sometimes sulphurous, belching.
This is the same underlying mechanism behind the nausea, indigestion and reflux that appear on Wegovy's known side-effect profile. If you have already read about nausea on Wegovy, burping fits into the same picture. The NHS semaglutide medicines page lists burping explicitly among the common gastrointestinal effects, so it is not a quirk, it is expected, documented, and shared by a meaningful proportion of people starting treatment.
The timing matters too. Burping almost always peaks in the first fortnight after starting a new dose level. Once gastric emptying partially adapts, the intensity tends to drop. You may notice it returns, at a lower level, with each step up the titration schedule, that is normal and not a reason to stop without talking to your prescriber first.
For many, the question is not whether the burping will happen but how much disruption they are willing to tolerate while it settles. A few practical factors help frame that decision.
First, duration. If burping arrived in week one and is already fading by week two, it is almost certainly transient and the sensible approach is to give it another week. If it has been four weeks and is genuinely affecting your quality of life (disruptive at work, uncomfortable at mealtimes, disturbing sleep) then it is worth raising at your next clinical review rather than waiting.
Second, associated symptoms. Burping on its own, even frequently, is not usually a warning sign. Burping combined with severe, persistent stomach pain that radiates toward the back is different: the full Wegovy side-effect profile includes rare but serious effects, and that symptom pattern specifically warrants prompt medical attention in line with MHRA guidance on GLP-1 medicines and pancreatitis risk.
Third, lifestyle adjustment. A surprisingly large number of people find that simple changes (eating at about half their usual speed, cutting out fizzy drinks and sparkling water, keeping portions modest even when hunger drops) substantially reduce belching within days. Keeping the pen in the fridge door next to the same yoghurt you have every morning is a useful cue to pair your injection with a routine, but the meal that follows is where you have the most control over symptoms.
The gas-reduction strategies that work for Wegovy-related burping are straightforward. Eat slowly enough that you register fullness before you overshoot it; semaglutide already lowers your appetite threshold, so the portions your body wants will be smaller than you expect. Chewing thoroughly reduces the volume of air swallowed with each mouthful. Avoiding carbonated drinks entirely for the first month of a new dose is the single change our prescribers hear patients credit most.
Fatty and spicy foods slow gastric emptying further on top of the medicine's own effect, cutting back on both, at least temporarily, can noticeably reduce burping. Caffeine and alcohol can aggravate reflux at the same time, so moderating those is worth trying too.
If you are considering whether the overall cost and experience of Wegovy is right for you, the Wegovy cost guide sets out what private treatment typically includes across providers. For broader context on how semaglutide is dispensed privately in the UK, the Wegovy overview page covers the full treatment picture.
It is also worth knowing that burping is not unique to Wegovy among this class of medicines. People on the semaglutide injection more broadly report similar GI patterns, and the detailed guide to belching on semaglutide covers the subject in more depth if you want to compare notes.
Most burping on Wegovy does not need urgent attention, but some situations do. Contact your prescriber sooner rather than later if: burping is accompanied by vomiting that prevents you from keeping fluids down for more than 24 hours; you develop signs of dehydration such as dark urine, dizziness or rapid heart rate; or you notice persistent upper-abdominal pain that does not settle. The fatigue that sometimes accompanies GI upset is worth flagging too, since dehydration and poor oral intake compound tiredness quickly.
The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is where patients and clinicians can report unexpected or severe side effects, using it helps regulators build a clearer picture of real-world GLP-1 experience.
If you are weighing up whether to start Wegovy or wondering whether the side-effect profile suits you, a prescriber can talk through your specific circumstances. Check your eligibility and start a free consultation to have that conversation with one of our GPhC-registered prescribers, the same day you apply.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.